KRAS and leukoencephalopathy with calcifications and cysts: KRAS mutation rates in AC, SCC, and LCC were 7.1% (24/340), 1.5% (2/132), and 3.8% (1/26), respectively (X2 = 6.124, P = 0.039, Fisher’s exact test,).